Bespoke Extracts, Inc. Overview
Industry: Drug Manufacturers Specialty & Generic
Sector: Healthcare
Bespoke Extracts, Inc. provides hemp-derived cannabidiol (CBD) products. The company offers CBD formulations, including manuka honey and in the form of lotions and balms; and markets CBD extracts in capsule form, topicals, and gummies. It offers its products through its direct to consumers e-commerce store bespokeextracts.com. The company was formerly known as DiMi Telematics International, Inc. and changed its name to Bespoke Extracts, Inc. in March 2017. The company is headquartered in Denver, Colorado.
Bespoke Extracts, Inc. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review Bespoke Extracts, Inc. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
Bespoke Extracts, Inc. Competitors
Bespoke Extracts, Inc. operates in the Drug Manufacturers Specialty & Generic industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans